|
May 7
|
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth
|
|
May 7
|
Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats
|
|
May 7
|
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
|
|
May 6
|
Top Analyst Reports for Novo Nordisk, Honeywell & American Tower
|
|
May 6
|
Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18%
|
|
May 6
|
Wall Street Punishes HIMS--Right After It Lands a Blockbuster Weight Loss Deal
|
|
May 6
|
Q1 2025 Hims & Hers Health Inc Earnings Call
|
|
May 6
|
How students at Roaring Kitty’s high school became top stock pickers
|
|
May 6
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|
|
May 6
|
Novo Nordisk A/S: ECO 2025 - Novo Nordisk semaglutide data shows new health benefits across serious chronic diseases
|
|
May 6
|
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas
|
|
May 6
|
Best-Performing Leveraged ETFs of Last Week
|
|
May 6
|
Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
|
|
May 5
|
5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates
|
|
May 5
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
|
May 5
|
FDA accepts Novo Nordisk’s NDA submission for weight management therapy
|
|
May 5
|
With compounders out of the way, Lilly and Novo go after each other
|
|
May 4
|
Is Novo Nordisk A/S (NVO) The Best Stock to Buy and Hold For 10 Years?
|
|
May 4
|
What is CVS? 'We are ... working through that very question'
|
|
Mar 14
|
Drugmakers agree to participate in second round of price negotiations
|